This workshop addressed a variety of models that capitalize upon the diversity of genetic variability and knowledge available in the mouse. Speakers described the model, and discussed the practical aspects of the proposed context of use for safety assessment. Where possible, speakers discussed relevant data that highlights the utility of the model under discussion. Formal talks were followed by a discussion session with the audience to address best practices for the use of these models in pharmaceutical development.
Please click here for the workshop agenda.
Please contact Dr. Raegan O’Lone at firstname.lastname@example.org, for additional information.